Yutaka Niihara - Net Worth and Insider Trading

Yutaka Niihara Net Worth

The estimated net worth of Yutaka Niihara is at least $1 Million dollars as of 2024-05-11. Yutaka Niihara is the Chairman and CEO, 10% Owner of Emmaus Life Sciences Inc and owns about 12,196,651 shares of Emmaus Life Sciences Inc (EMMA) stock worth over $1 Million. Details can be seen in Yutaka Niihara's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Yutaka Niihara has not made any transactions after 2022-11-30 and currently still holds the listed stock(s).

Transaction Summary of Yutaka Niihara

To

Yutaka Niihara Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yutaka Niihara owns 1 companies in total, including Emmaus Life Sciences Inc (EMMA) .

Click here to see the complete history of Yutaka Niihara’s form 4 insider trades.

Insider Ownership Summary of Yutaka Niihara

Ticker Comapny Transaction Date Type of Owner
EMMA Emmaus Life Sciences Inc 2022-11-30 director & 10 percent owner & Chairman and CEO

Yutaka Niihara Latest Holdings Summary

Yutaka Niihara currently owns a total of 1 stock. Yutaka Niihara owns 12,196,651 shares of Emmaus Life Sciences Inc (EMMA) as of November 30, 2022, with a value of $1 Million.

Latest Holdings of Yutaka Niihara

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EMMA Emmaus Life Sciences Inc 2022-11-30 12,196,651 0.11 1,280,648

Holding Weightings of Yutaka Niihara


Yutaka Niihara Form 4 Trading Tracker

According to the SEC Form 4 filings, Yutaka Niihara has made a total of 120 transactions in Emmaus Life Sciences Inc (EMMA) over the past 5 years, including 120 buys and 0 sells. The most-recent trade in Emmaus Life Sciences Inc is the acquisition of 52,600 shares on November 30, 2022, which cost Yutaka Niihara around $21,040.

Insider Trading History of Yutaka Niihara

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yutaka Niihara Trading Performance

GuruFocus tracks the stock performance after each of Yutaka Niihara's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yutaka Niihara is -1.41%. GuruFocus also compares Yutaka Niihara's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yutaka Niihara within 3 months outperforms 35 times out of 118 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Yutaka Niihara's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Yutaka Niihara

Average Return

Average return per transaction

Outperforming Transactions

29 out of 119 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.99
Relative Return to S&P 500(%) 1.76

Yutaka Niihara Ownership Network

Ownership Network List of Yutaka Niihara

No Data

Ownership Network Relation of Yutaka Niihara


Yutaka Niihara Owned Company Details

What does Emmaus Life Sciences Inc do?

Who are the key executives at Emmaus Life Sciences Inc?

Yutaka Niihara is the director & 10 percent owner & Chairman and CEO of Emmaus Life Sciences Inc. Other key executives at Emmaus Life Sciences Inc include director & Vice Chairman & COO Willis C Lee , CIO & SVP George Sekulich , and SVP & Clinical Development Charles William Stark .

Emmaus Life Sciences Inc (EMMA) Insider Trades Summary

Over the past 18 months, Yutaka Niihara made 1 insider transaction in Emmaus Life Sciences Inc (EMMA) with a net purchase of 52,600. Other recent insider transactions involving Emmaus Life Sciences Inc (EMMA) include a net purchase of 251,809 shares made by Willis C Lee , a net purchase of 100,700 shares made by Seah H. Lim ,

In summary, during the past 3 months, insiders sold 0 shares of Emmaus Life Sciences Inc (EMMA) in total and bought 115,200 shares, with a net purchase of 115,200 shares. During the past 18 months, 38,500 shares of Emmaus Life Sciences Inc (EMMA) were sold and 443,609 shares were bought by its insiders, resulting in a net purchase of 405,109 shares.

Emmaus Life Sciences Inc (EMMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emmaus Life Sciences Inc Insider Transactions

No Available Data

Yutaka Niihara Mailing Address

Above is the net worth, insider trading, and ownership report for Yutaka Niihara. You might contact Yutaka Niihara via mailing address: 20725 S. Western Blvd., Suite 136, Torrance Ca 90501.

Discussions on Yutaka Niihara

No discussions yet.